FDA Needs Plan To Regulate Clinical Software, Group Says
A health technology group is urging the U.S. Food and Drug Administration to address narrow regulatory questions on clinical software products, a request that stems from years of delay in producing...To view the full article, register now.
Already a subscriber? Click here to view full article